文献速递妇科生殖医学

米非司酮和米索前列醇用于不想要的未知部位妊娠

Mifepristone and Misoprostol for Undesired Pregnancy of Unknown Location.
PubMed 文献 · Obstet Gynecol · 2022-04-05

这项回顾性队列研究使用马萨诸塞州计划生育联盟2014-2019年电子病历数据,比较未知部位妊娠患者立即与延迟启动药物流产。立即启动组排除异位妊娠更快、流产完成更快,但药物流产成功率较低(85.4% vs 96.7%;P=.013),持续妊娠率较高(10.4% vs 2.5%;P=.041)。

要点

  • 未知部位妊娠立即启动药物流产可更快排除异位妊娠(中位5.0天 vs 9.0天;P=.005)。
  • 立即启动组流产完成时间更短(中位5.0天 vs 19.0天;P<.001),但流产成功率更低(85.4% vs 96.7%;P=.013)。
  • 延迟诊断组31例(7.9%)接受异位妊娠治疗,其中4例破裂。

核心结论

  • 在不想要的未知部位妊娠患者中,立即启动药物流产与更快排除异位妊娠和终止妊娠相关,但流产效力较低。

研究设计与样本

  • 回顾性队列研究,使用马萨诸塞州计划生育联盟2014-2019年电子病历数据,纳入末次月经≤42天且初始超声无妊娠囊的未知部位妊娠患者。
  • 同日开始组在连续血清人绒毛膜促性腺激素(hCG)检测排除异位妊娠的同时启动米非司酮序贯米索前列醇药物流产;延迟诊断组先通过连续hCG检测和重复超声确立诊断后再启动治疗。

主要发现

  • 在5,619次末次月经≤42天的药物流产就诊中,452例(8.0%)为未知部位妊娠;3例立即行子宫吸引术,55例同日开始,394例延迟诊断。
  • 31例(7.9%)接受异位妊娠治疗,全部在延迟诊断组,其中4例破裂。
  • 在无主要异位妊娠危险因素的患者(n=432)中,同日开始组诊断时间更短(中位5.0天 vs 9.0天;P=.005),急诊就诊(aOR 0.90,95%CI 0.43-1.88)和随访不依从(aOR 0.92,95%CI 0.39-2.15)无显著差异。
  • 在继续流产的患者(n=270)中,同日开始组流产完成时间更短(中位5.0天 vs 19.0天;P<.001)。
  • 在药物流产结局已知的患者(n=170)中,同日开始组流产成功率更低(85.4% vs 96.7%;P=.013),持续妊娠率更高(10.4% vs 2.5%;P=.041)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To compare immediate initiation with delayed initiation of medication abortion among patients with an undesired pregnancy of unknown location. METHODS: This retrospective cohort study used electronic medical record data from the Planned Parenthood League of Massachusetts (2014-2019) for patients who requested medication abortion with a last menstrual period (LMP) of 42 days or less and pregnancy of unknown location (no gestational sac) on initial ultrasonogram. Clinicians could initiate medication abortion with mifepristone followed by misoprostol while simultaneously excluding ectopic pregnancy with serial serum human chorionic gonadotropin (hCG) testing (same-day-start group) or establish a diagnosis with serial hCG tests and repeat ultrasonogram before initiating treatment (delay-for-diagnosis group). We compared primary safety outcomes (time to diagnosis of pregnancy location [rule out ectopic], emergency department visits, adverse events, and nonadherence with follow-up) between groups. We also reported secondary efficacy outcomes: time to complete abortion, successful medication abortion (no uterine aspiration), and ongoing pregnancy. RESULTS: Of 5,619 medication abortion visits for patients with an LMP of 42 days or less, 452 patients had pregnancy of unknown location (8.0%). Three patients underwent immediate uterine aspiration, 55 had same-day start, and 394 had delay for diagnosis. Thirty-one patients (7.9%), all in the delay-for-diagnosis group, were treated for ectopic pregnancy, including four that were ruptured. Among patients with no major ectopic pregnancy risk factors (n=432), same-day start had shorter time to diagnosis (median 5.0 days vs 9.0 days; P=.005), with no significant difference in emergency department visits (adjusted odds ratio [aOR] 0.90, 95% CI 0.43-1.88) or nonadherence with follow-up (aOR 0.92, 95% CI 0.39-2.15). Among patients who proceeded with abortion (n=270), same-day start had shorter time to complete abortion (median 5.0 days vs 19.0 days; P<.001). Of those who had medication abortion with known outcome (n=170), the rate of successful medication abortion was lower (85.4% vs 96.7%; P=.013) and the rate of ongoing pregnancy was higher (10.4% vs 2.5%; P=.041) among patients in the same-day-start group. CONCLUSION: In patients with undesired pregnancy of unknown location, immediate initiation of medication abortion is associated with more rapid exclusion of ectopic pregnancy and pregnancy termination but lower abortion efficacy.

来源:Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Goldberg AB, Fulcher IR, Fortin J, et al. Mifepristone and Misoprostol for Undesired Pregnancy of Unknown Location. Obstet Gynecol. 2022. PMID: 35576336. doi:10.1097/AOG.0000000000004756

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。